AAAAAA
Results:
1-19
|
Results: 19
Authors:
GIBALDI M
Citation: M. Gibaldi, REGULATING ANGIOGENESIS - A NEW THERAPEUTIC STRATEGY, Journal of clinical pharmacology, 38(10), 1998, pp. 898-903
Authors:
GIBALDI M
Citation: M. Gibaldi, PREVENTION AND TREATMENT OF STROKE - WHERE DO WE STAND, Journal of clinical pharmacology, 37(9), 1997, pp. 784-790
Authors:
GIBALDI M
SULLIVAN S
Citation: M. Gibaldi et S. Sullivan, INTENTION-TO-TREAT ANALYSIS IN RANDOMIZED TRIALS - WHO GETS COUNTED, Journal of clinical pharmacology, 37(8), 1997, pp. 667-672
Authors:
GIBALDI M
Citation: M. Gibaldi, PREVENTION AND TREATMENT OF OSTEOPOROSIS - DOES THE FUTURE BELONG TO HORMONE REPLACEMENT THERAPY, Journal of clinical pharmacology, 37(12), 1997, pp. 1087-1099
Authors:
GIBALDI M
Citation: M. Gibaldi, THE 11TH INTERNATIONAL-CONFERENCE ON AIDS - CAUTIOUS CELEBRATION IN VANCOUVER, Journal of clinical pharmacology, 37(1), 1997, pp. 20-24
Authors:
GIBALDI M
Citation: M. Gibaldi, HORMONE REPLACEMENT THERAPY - ESTROGEN AFTER MENOPAUSE, Pharmacotherapy, 16(3), 1996, pp. 366-375
Authors:
GIBALDI M
Citation: M. Gibaldi, FAILURE TO COMPLY - A THERAPEUTIC DILEMMA AND THE BANE OF CLINICAL-TRIALS, Journal of clinical pharmacology, 36(8), 1996, pp. 674-682
Authors:
GIBALDI M
KRADJAN W
Citation: M. Gibaldi et W. Kradjan, TREATING ELEVATED CHOLESTEROL LEVELS - THE GREAT SATAN IN PERSPECTIVE, Journal of clinical pharmacology, 36(3), 1996, pp. 189-197
Authors:
GIBALDI M
Citation: M. Gibaldi, ANTIOXIDANT VITAMINS AND HEALTH, Journal of clinical pharmacology, 36(12), 1996, pp. 1093-1099
Authors:
GIBALDI M
Citation: M. Gibaldi, VERTICAL INTEGRATION - THE DRUG-INDUSTRY AND PRESCRIPTION BENEFITS MANAGERS, Pharmacotherapy, 15(3), 1995, pp. 265-271
Authors:
GIBALDI M
Citation: M. Gibaldi, HELICOBACTER-PYLORI AND GASTROINTESTINAL-DISEASE, Journal of clinical pharmacology, 35(7), 1995, pp. 647-654
Authors:
GIBALDI M
WITTKOWSKY AK
Citation: M. Gibaldi et Ak. Wittkowsky, CONTEMPORARY USE OF AND FUTURE ROLES FOR HEPARIN IN ANTITHROMBOTIC THERAPY, Journal of clinical pharmacology, 35(11), 1995, pp. 1031-1045
Authors:
GIBALDI M
SULLIVAN SD
Citation: M. Gibaldi et Sd. Sullivan, A LOOK AT COST-EFFECTIVENESS, Pharmacotherapy, 14(4), 1994, pp. 399-414
Authors:
GIBALDI M
Citation: M. Gibaldi, STEREOSELECTIVE AND ISOZYME-SELECTIVE DRUG-INTERACTIONS, Chirality, 5(6), 1993, pp. 407-413
Authors:
GIBALDI M
Citation: M. Gibaldi, PRESCRIPTION DRUGS AND HEALTH-CARE REFORM, Pharmacotherapy, 13(6), 1993, pp. 583-589
Authors:
GIBALDI M
Citation: M. Gibaldi, ANATOMY OF AN ANTIBODY, AND RELATED MISADVENTURES IN DEVELOPING AN EFFECTIVE TREATMENT FOR SEPTIC SHOCK, Pharmacotherapy, 13(4), 1993, pp. 302-308
Authors:
GIBALDI M
Citation: M. Gibaldi, ETHNIC-DIFFERENCES IN THE ASSESSMENT AND TREATMENT OF DISEASE, Pharmacotherapy, 13(3), 1993, pp. 170-176
Authors:
GIBALDI M
Citation: M. Gibaldi, WHAT IS NITRIC-OXIDE AND WHY ARE SO MANY PEOPLE STUDYING IT, Journal of clinical pharmacology, 33(6), 1993, pp. 488-496
Authors:
GIBALDI M
Citation: M. Gibaldi, METAANALYSIS - A REVIEW OF ITS PLACE IN THERAPEUTIC DECISION-MAKING, Drugs, 46(5), 1993, pp. 805-818
Risultati:
1-19
|